Order Article Reprints

Piazzetta GL, Di Agostino S, Lobello N, Aloisio A, Di Vito A, Bria J, Filardo A, Coscarella I, Preianò M, Pelaia C, et al. Preliminary Effects of Benralizumab in an AML Cell Model with Promyelocytic Features Expressing IL-5R: An Exploratory Proof-of-Concept Study. Biomedicines. 2026; 14(3):652. https://doi.org/10.3390/biomedicines14030652

Piazzetta, Giovanna Lucia, Silvia Di Agostino, Nadia Lobello, Annamaria Aloisio, Anna Di Vito, Jessica Bria, Andrea Filardo, Isabella Coscarella, Mariaimmacolata Preianò, Corrado Pelaia, and et al. 2026. "Preliminary Effects of Benralizumab in an AML Cell Model with Promyelocytic Features Expressing IL-5R: An Exploratory Proof-of-Concept Study" Biomedicines 14, no. 3: 652. https://doi.org/10.3390/biomedicines14030652

Piazzetta, G. L., Di Agostino, S., Lobello, N., Aloisio, A., Di Vito, A., Bria, J., Filardo, A., Coscarella, I., Preianò, M., Pelaia, C., Lombardo, N., & Chiarella, E. (2026). Preliminary Effects of Benralizumab in an AML Cell Model with Promyelocytic Features Expressing IL-5R: An Exploratory Proof-of-Concept Study. Biomedicines, 14(3), 652. https://doi.org/10.3390/biomedicines14030652